Phase 2 Heart Transplant Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Belatacept in Heart Transplantation
Heart Transplant
National Institute of Allergy and Infectious Diseases (NIAID)66 enrolled5 locationsNCT06478017
Recruiting
Phase 2
Study of Organ Perfusion in Heart Transplantation in Children
Heart Transplantation
Dr. F. Köhler Chemie GmbH15 enrolled3 locationsNCT06032195
Recruiting
Phase 2
Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
Heart Transplant Failure
Nantes University Hospital25 enrolled4 locationsNCT04180085
Recruiting
Phase 2
Belatacept in De Novo Heart Transplantation
Heart Transplantation
NYU Langone Health12 enrolled2 locationsNCT04477629
Recruiting
Phase 2Phase 3
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735
Recruiting
Phase 2
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
Acute Kidney InjuryHeart Transplantation
Fernando Bacal74 enrolled1 locationNCT05909150
Recruiting
Phase 1Phase 2
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
Heart Transplantation
Rafael Correa-Rocha11 enrolled1 locationNCT04924491